AVTX Avalo Therapeutics, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
13:05
Aug 17
Aug 17
Shares options positioning net conviction data.
Shares options positioning data showing net conviction based on fund holdings, no directional view.
MED
12:53
Aug 17
Aug 17
Reports widest ownership across specialist funds
"Reports widest Q2 2026 ownership across 95 specialist funds based on 13F filings, no directional view."
MED
12:52
Aug 17
Aug 17
Reports most closed positions across funds
"Reports most closed positions across specialist funds in Q2 2026 excluding M&A take-outs, no directional view."
MED
12:49
Aug 17
Aug 17
Reports most added positions across funds
"Reports most added positions across specialist funds from Q1 to Q2 2026, no directional view."
MED
11:58
Aug 17
Aug 17
Reports widest Q2 ownership among specialist funds
Reports the widest Q2 2026 ownership across 93 specialist funds based on 13F filings.
MED
11:57
Aug 17
Aug 17
Reports most closed positions by specialist funds
Reports the most closed positions by specialist funds in Q2 2026, excluding M&A takeouts.
MED
11:55
Aug 17
Aug 17
Reports most new positions by specialist funds
Reports the most new positions and fresh initiations by specialist funds in Q2 2026.
MED
11:50
Aug 17
Aug 17
Reports most added positions by specialist funds
Reports the most added positions by specialist funds from Q1 to Q2 2026.
MED
17:25
Aug 10
Aug 10
Highlights past successful biotech valuation calls.
Author lists numerous biotech and pharma tickers as past successful valuation calls, offering no current directional view.
LOW
20:17
May 05
May 05
Bearish view on AVTX due to excessive buyer enthusiasm and delta behavior indicating a crowded.
Bearish view on AVTX due to excessive buyer enthusiasm and delta behavior indicating a crowded, unsustainable move likely to reverse.
HIGH
20:06
May 05
May 05
The author expresses a bearish view on Avita Therapeutics.
The author expresses a bearish view on Avita Therapeutics, noting that many had correctly predicted its poor performance and offering condolences.
HIGH
About AVTX Analyst Coverage
Buzzberg tracks AVTX (Avalo Therapeutics, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 11 total trade ideas tracked. Latest voices: seedy19tron.